Background: Peptidoglycan (PGN) is a component of cell wall in Gram-positive bacteria that stimulates inflammatory responses through Toll-like receptor 2 (TLR2). The carboxyl terminus of constitutive heat shock cognate 70 (HSC70)-interacting protein (CHIP, also known as Stub1) is a U-box-type E3 ubiquitin ligase, which plays an important role in protein quality control and inflammation through ubquitin-mediated proteasomal degradation. However, it is unclear whether TLR2 agonist PGN regulates the expression and activation of CHIP. Methods/Results: In this study, we showed that PGN significantly up-regulated the expression of CHIP in both mRNA and protein levels in RAW264.7 cells in a time-dependant manner, and the expression of CHIP induced by PGN was abolished in TLR2 knockout macrophages. No significant change in CHIP was observed after lipopolysaccharide (LPS, TLR4 agonist) and cytosinephosphorous-guanine oligonucleotide (CpG ODN, TLR9 agonist) treatment. Moreover, PGN markedly induced the expression and activity of CHIP in macrophages, whereas this effect was attenuated by SP600125, a selective inhibitor of JNK. Conclusion: Our study for the first time demonstrates that TLR2 activation enhances the expression and activity of CHIP through JNK signaling pathway.
Toll-Like Receptor-2 Ligand Peptidoglycan Upregulates Expression and Ubiquitin Ligase Activity of CHIP through JNK Pathway

Introduction
Sepsis is caused by the immune system's response to a serious infection, most commonly bacteria. Despite substantial prevention efforts to improve patient outcome, Gram-positive bacteria are still the predominant organisms in sepsis case since 19th century [1] . Toll-like receptors (TLRs) are pattern recognition receptors (PRRs) of innate immune system that recognize conserved microbial structures called PAMPs (pathogen-associated molecular patterns), including lipopolysaccharide (LPS), peptidoglycan (PGN), cytosine-phosphorousguanine oligonucleotide (CpG ODN). LPS is a major component of the outer membrane of Gram negative bacteria, while PGN (also known as murein) serves a structural component in cell wall of Gram-positive bacteria. CpG ODNs are synthetic oligonucleotides containing CpG motifs [2] . Increasing studies have demonstrated that PAMPs (such as LPS, PGN and CpG ODNs) activates host cells through the pattern recognition receptors Toll-like receptors (such as TLR4, TLR2 and TLR9), which play important roles in both innate and adaptive immunity [3, 4] . The MAPKs are serine/threonine signaling kinases that mediate the phosphorylation and activation of transcription factors. There are three main members of MAPK family in mammalian cells stress-activated protein kinase c-Jun NH2-terminal kinase (JNK), stressactivated protein kinase 2 (SAPK2 or p38) and the extracellular signal-regulated protein kinases (ERK1/2, p44/p42) [5] . MAPKs are activated by not only cellular stresses such as hypoxic and oxidative stress, but also proinflammatory cytokines, including TNFα, IL-6, IL-1 or LPS [6] [7] [8] . Recently, Bhatt et al found that PGN activates MAPK pathway in mouse peritoneal macrophages, which results in the expression of inducible Nitric Oxide [9] .
The ubiquitin-proteasome system (UPS) is responsible for the degradation and clearance of unneeded or damaged intracellular proteins to maintain the cell homeostasis [10, 11] . C terminus of Hsp70-interacting protein (CHIP) is a U-box-dependent E3 ubiquitin ligase which is highly expressed in human striated muscle, aortic smooth muscle cells (SMCs), and endothelial cell [12] . Increasing evidence suggests that CHIP plays a critical role in the regulation of cell growth, apoptosis, neurodegeneration, invasion, SMC differentiation and cardiac fibrosis [13] [14] [15] . Recently, it is reported that CHIP also participates in innate immunity through TLR4 and TLR9, rather than TLR3-driven pathway. CHIP acts as an E3 ligase for Src and PKC in TLR4 and TLR9-driven signaling [16] . It has been known that the expression of CHIP can be regulated by acute injury, such as hypoxia, ischemia, ischemia/ reperfusion (I/R) injury and angiotensin II (Ang II) [13, 17, 18] . However, it is unclear whether TLR-driven pathway plays a role in the regulation of CHIP expression.
In the present study, we aimed to explore whether TLR2 signaling regulates expression and activity in the RAW264.7 macrophages. Here we demonstrated that TLR2 agonist PGN up-regulated the expression of CHIP in mRNA and protein levels in a time-dependant manner, and this effect of PGN on CHIP expression was abolished in TLR2-deficient macrophages. Moreover, PGN-induced expression and activity of CHIP were significantly attenuated by a selective inhibitor of JNK, SP600125. Thus, the present study for the first time revealed that TLR2 agonist PGN increased the expression and activity of E3 ligase CHIP by the activation of JNK signaling pathway.
Materials and Methods
Antibodies and Reagents
Dulbecco modified Eagle medium (DMEM), trypsin and fetal calf serum (FCS) were purchased from Hyclone (South Logan, UT). The anti-CHIP and anti-β-actin antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). The anti-Ub antibody was purchased from Chemicon International Inc. Cellular Physiology and Biochemistry SB203580 (p38 inhibitor) and PD98059 (ERK inhibitor) were purchased from Calbiochem (La Jolla, CA). All other chemicals were from Sigma-Aldrich (St Louis, MO), unless specified otherwise.
Cell culture and treatment
Raw 264.7 cell line was purchased from ATCC and cultured in DMEM supplemented with 10% fetal calf serum, penicillin (100 U/ml), and streptomycin (100 mg/ml) at 37℃ under a humidified atmosphere of 95% air and 5% CO 2 . To evaluate the involvement of signaling pathways in TLR agonist-induced expression of CHIP, cells were pretreated with SB203580 (p38 MAPK inhibitor, 10 μM), PD98059 (ERK1/2 inhibitor, 10 μM), SP600125 (JNK inhibitor, 10 μM) for 0.5 h and then treated with LPS (200 ng/ml), PGN (10 μg/ml) and CpG ODN (1 μg/ml) for the indicated time points.
Mice Pathogen-free female TLR2 -/-mice and their wild-type controls were purchased from The Jackson Laboratories (Bar Harbor, ME). Animal protocols were approved by the Animal Care and Use Committee of Capital Medical University. The investigation conformed to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH publication no. 85-23, revised 1996).
Isolation of peritoneal macrophages
Mice (8-week-old male) were injected intraperitoneally with 3 ml of 3% thioglycolate. After 3 days, peritoneal cells were collected by peritoneal lavage using 10 ml ice-cold phosphate-buffered saline (PBS) , centrifuged at 1,000 rpm for 10 min, resuspended in RPMI1640 media supplemented 10% fetal bovine serum, and incubated on the 24-well plate for 1 h and then used for the experiments as described [19] .
Quantitative real-time PCR analysis
Total RNA was purified from cultured cells with Trizol (Invitrogen). Specific primers used for quantitative real-time PCR (qPCR) assays were 5'-TGGAGAGTTATGATGAGGCCA-3' (sense) and 5'-GCGAAGGGCACTAGGAATATC-3' (anti-sense) for CHIP, and 5'-AGGTCGGTGTGAACGGATTTG-3' (sense) and 5'-TGTAGACCATGTAGTTGAGGTCA-3' (anti-sense) for GAPDH. qRT-PCR was performed on an iQ5 RealTime PCR Detection System (Bio-Rad Laboratories) according to the manufacturer's protocol [20] .
Western Blot and Immunoprecipitation analysis
Western blot analysis was performed as previously described [17] . The cells were lysed with extraction buffer (50 mmol/L Tris-HCl pH 7.5, 0.5% Triton X-100, 0.5% NP40, 150 mmol/L NaCl, 2 mmol/L EDTA, 1 mmol/L NaF, 1 mmol/L PMSF, 1 mmol/L Na 3 VO 4 , and 10% protease inhibitors). Fifty-sixty micrograms of extracts were separated by SDS-PAGE on a 10% gel and were transferred to a nitrocellulose membrane. The membranes were incubated with primary antibodies against CHIP (1:1000), JNK (1:500), ERK (1:1000), p38 MAPK (1:500) and β-actin (1:2000) overnight, then incubated with an HRP-conjugated secondary antibody for 1 h. The phospho-specific proteins were normalized to total target protein and β-actin. For immunoprecipitation assays, cell lysates were precleared with protein A/G-Sepharose (50% slurry equilibrated in phosphate-buffered saline) for 2 h at 4°C and then incubated with 5 μg of anti-CHIP antibody for 4 h at 4°C. Protein A/G-Sepharose was added and incubated for an additional 1 h at 4°C to capture primary immune complexes. The beads were washed and fractionated by 10% SDS-PAGE followed by immunoblotting as previously described [21, 22] . 
Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry
MAPK inhibitor, 10 μM) and PD98059 (ERK MAPK inhibitor, 10 μM) were used to treat cells for 30 min before 2 hour incubation with 10 μg/ml of PGN. As shown in Fig. 4B , SP600125 significantly inhibited PGN-induced expression of CHIP mRNA, whereas SB203580, PD98059 had no effect. Collectively, these data indicate that JNK pathway plays a critical role in PGNinduced expression of CHIP in macrophages.
PGN enhances ubiquitin ligase activity of CHIP
As an ubiquitin ligase, CHIP interaction with the molecular chaperones results in client substrate ubiquitination and degradation by the 26S proteasome [26] . We then determined whether PGN affects the ubiquitin ligase activity of CHIP. After treatment with PGN at the indicated points, cell extracts were immunoprecipitated with anti-CHIP antibody and immunoblotted with an anti-Ub. We found that ubiquitination of CHIP increased in a timedependent manner following PGN treatment (Fig. 5) . Thus, these data indicate that PGN can increase the ubiquitin ligase activity of CHIP in macrophages.
PGN increases ubiquitin ligase activity of CHIP though JNK pathway
We then investigated the molecular mechanism by which PGN increases ubiquitin ligase activity of CHIP in macrophages. Since PGN induces phosphorylation of JNK, p38, and ERK, we then used specific MAPK inhibitors to pretreat RAW 264.7 with SP600125 (10 μM), SB203580 (10 μM), PD98059 (10 μM) for 30 min before 8 hours incubation with 10 μg/ml of PGN. As shown in Fig. 6 , SP600125 significantly inhibited the PGN-induced ubiquitination of CHIP, whereas SB203580 and PD98059 had no effect after PGN stimulation. Together, these data indicate that JNK pathway plays a critical role in the PGN-induced increase in CHIP activity. 
Discussion
In this study, we for the first time demonstrated that the TLR2 agonist PGN stimulation drastically increased CHIP mRNA and protein expression in macrophages. These effects were predominantly mediated via the TLR2-JNK pathway. Moreover, PGN-induced activation of ubiquitin ligase activity of CHIP was markedly attenuated by JNK inhibitor. Thus, these results demonstrated that PGN regulates the expression and ubiquitin ligase activity of CHIP through JNK pathway.
CHIP is a U-box-dependent E3 ubiquitin ligase and cochaperone protein [12] . It contains three major structural domains. In addition to its well-characterized three-tetratricopeptide repeats (TRP) domain that allows it to interact with chaperones such as Hsc70/Hsp70 and Hsp90, it also has charged domain, and U-box domain that confers E3 ubiquitin ligase activity and facilitates the polyubiquitination of chaperone substrates [13] . Studies have shown that CHIP plays important roles in the regulation of pathophysiological processes through promoting the degradation of various target proteins including cystic fibrosis transmembrane conductance regulator (CFTR), ErBB2, Foxo1, myocardin, Ask1, p53, Tau, and ataxin 1 proteins [27, 28] . Several studies have demonstrated that the expression of CHIP at mRNA and protein levels is regulated by various factors. Hypoxia, I/R injury, BAG-2 and cochaperone HspBP1 inhibit the expression of ubiquitin ligase activity of CHIP. In contrast, heat shock and Ang II treatment have opposite effect [29, 30] , but the underlying mechanisms remain poorly understood. Recently, it has been shown that CHIP plays an important role in regulating inflammatory responses. Overexpression of CHIP significantly suppressed Ang II-induced macrophage infiltration and expression of proinflammatory cytokines though NF-kB and MAPK signaling pathways [17] . CHIP also participates in innate immunity through TLR4 and TLR9 [16] . However, whether TLR signaling pathway regulates CHIP expression and ligase activity of CHIP and the underlying mechanisms remain to be explored.
TLRs family includes several receptors, including TLR2, which plays important roles in cardiovascular diseases such as infarction, restenosis, atherosclerosis and cardiomyopathy [31] . PGN is a major cell wall component of Gram-positive bacteria. Unlike LPS that is recognized by TLR4, PGN is recognized by TLR2 and then activates MAPKs pathway and induces production of inflammatory cytokines [31] . The MAPKs, including JNK, p38, and ERK, play an important role in regulating macrophage to induce the production of inflammatory cytokines during various pathological insults. It has been shown that PGN induces MAPKs activation in macrophage, thereby leads to expression of inducible nitric oxide synthase and NO [9] . However little is understood about the role of PGN in the regulation of CHIP. In this study, our data indicated that TLR2 agonist PGN dramatically increased CHIP expression in mRNA and protein levels ( Fig. 1 and 2 ), whereas this effect of PGN on CHIP expression was abolished in TLR2 KO macrophages (Fig. 3) . Moreover, specific inhibition of JNK with SP600125 markedly attenuated PGN-induced expression of CHIP, whereas a specific p38 MAPK and ERK inhibitors had no effect (Fig. 4B) .These data suggest that activation of JNK is required for PGN-induced expression of CHIP in macrophages.
Increasing evidence suggests that the ubiquitin-proteasome system is responsible for the degradation of misfolded proteins [32] . The process of protein degradation by ubiquitination is mediated by enzymes known as E1, E2, and E3. As an E3 ligase, we wondered whether the increased expression of CHIP induced by PGN could associate with the increased ubiqitin ligase activity of CHIP. We found that PGN treatment also enhanced CHIP ligase activity in a time-dependent manner (Fig. 5 ) and this action was attenuated by SP600125, an inhibitor of JNK pathway. These data further demonstrate that PGN up-regulates both expression of CHIP and ubiqitin ligase activity through JNK signaling pathway in macrophages.
In conclusion, we provide novel evidence that TLR2 agonist PGN promoted the expression and ubiquitin ligase activity of CHIP in macrophages via JNK signaling pathway. Thus, the present study has identified a novel mechanism of regulation of CHIP expression and activity by PGN, which implies a novel therapeutic role of JNK inhibition during bacterial
